GSPT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.313400E-01
Normal-vs-Stage2
4.554400E-01
Normal-vs-Stage3
2.870200E-01
Normal-vs-Stage4
8.296200E-02
Stage1-vs-Stage2
2.536600E-01
Stage1-vs-Stage3
2.797800E-01
Stage1-vs-Stage4
5.019900E-02
Stage2-vs-Stage3
4.202100E-02
Stage2-vs-Stage4
2.139800E-01
Stage3-vs-Stage4
2.585600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.860200E-01
Normal-vs-AfricanAmerican
2.912200E-01
Normal-vs-Asian
8.942200E-01
Caucasian-vs-AfricanAmerican
3.183400E-01
Caucasian-vs-Asian
4.507200E-01
AfricanAmerican-vs-Asian
2.226600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.538400E-01
Normal-vs-Female
5.903600E-01
Male-vs-Female
6.850400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.848200E-01
Normal-vs-Age(41-60Yrs)
3.632000E-01
Normal-vs-Age(61-80Yrs)
6.505800E-01
Normal-vs-Age(81-100Yrs)
7.935400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.857800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.381400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.774200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.644410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.886210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.179400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.704000E-01
Normal-vs-Daily Drinker
9.559000E-01
Normal-vs-Weekly Drinker
8.498800E-01
Normal-vs-Occasional Drinker
4.501000E-01
Normal-vs-Social Drinker
5.570400E-01
Non Drinker-vs-Daily Drinker
6.418200E-01
Non Drinker-vs-Weekly Drinker
8.971800E-01
Non Drinker-vs-Occasional Drinker
3.580600E-01
Non Drinker-vs-Social Drinker
6.430200E-01
Daily Drinker-vs-Weekly Drinker
8.057800E-01
Daily Drinker-vs-Occasional Drinker
2.184400E-01
Daily Drinker-vs-Social Drinker
4.127800E-01
Weekly Drinker-vs-Occasional Drinker
3.964400E-01
Weekly Drinker-vs-Social Drinker
6.211800E-01
Occasional Drinker-vs-Social Drinker
6.858400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.419200E-01
Normal-vs-Grade 2
7.519600E-02
Normal-vs-Grade 3
6.180400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.928000E-02
Grade 1-vs-Grade 3
7.170500E-02
Grade 1-vs-Grade 4
4.419200E-01
Grade 2-vs-Grade 3
9.851000E-01
Grade 2-vs-Grade 4
7.519600E-02
Grade 3-vs-Grade 4
6.180400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.901800E-01
Normal-vs-NonDiabetic
6.831200E-01
Diabetic-vs-NonDiabetic
9.878000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.671200E-01
Normal-vs-NoPancreatitis
6.576400E-01
Pancreatitis-vs-NoPancreatitis
7.752600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.265400E-01
Normal-vs-N1
4.685800E-01
N0-vs-N1
1.117990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.469600E-01
Normal-vs-TP53-NonMutant
2.911600E-01
TP53-Mutant-vs-TP53-NonMutant
2.174100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
